Guardian Pharmacy Q4 revenue $397.6M (+17% YoY), net income $21.3M (+81%); raises 2026 EBITDA guidance

Guardian Pharmacy Services, Inc.

Q4 diluted EPS $0.33, adjusted EPS $0.37; full-year diluted EPS $0.78, adjusted EPS $1.07.
Full-year revenue $1.45B (+18% YoY); net income $49.0M vs $71.0M loss in 2024.
2026 Adjusted EBITDA guidance raised to $120M–$124M (from $115M–$118M); revenue guidance unchanged $1.40B–$1.42B.
Cash $65.6M at year-end, no long-term debt outstanding under $75M credit facility.
Annualized return on equity approximately 27% in 2025; 54 full-service pharmacies after North Ridge acquisition.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Guardian Pharmacy Services, Inc. reported full year 2026 results: revenue $1.40 billion – $1.42 billion. Guidance raised.

Period: full year 2026
Revenue: $1.40 billion – $1.42 billion
Guidance: raised
Result: guidance update

Exact text from the filing

FY 2026 Outlook – Raising Adjusted EBITDA Guidance The guidance below excludes future acquisitions. Updated Guidance Previous Guidance Revenue $1.40 billion – $1.42 billion $1.40 billion – $1.42 billion Adjusted EBITDA $120 million – $124 million $115 million – $118 million

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Guardian Pharmacy Services, Inc. reported fourth quarter ended December 31, 2025 results: revenue $397.6 million, net income $21.3 million, EPS $0.33.

Period: fourth quarter ended December 31, 2025
Revenue: $397.6 million
Net income: $21.3 million
EPS: $0.33
Result: reported results

Exact text from the filing

Revenue of $397.6 million, up 17% year-over-year with organic growth of 12%. • Residents served ended the quarter at approximately 205,000, up 10% year-over-year. • Net Income of $21.3 million, up 81% from $11.8 million in the prior-year period. • Adjusted EBITDA of $39.5 million, up 53% year over year. • Diluted EPS of $0.33 for the quarter, with Adjusted EPS of $0.37.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Guardian Pharmacy Services, Inc. reported full year ended December 31, 2025 results: revenue $1.45 billion, net income $49.0 million, EPS $0.78.

Period: full year ended December 31, 2025
Revenue: $1.45 billion
Net income: $49.0 million
EPS: $0.78
Result: reported results

Exact text from the filing

Revenue of $1.45 billion, up 18% from $1.23 billion in the prior year period with organic growth of 13%. • Net Income (loss) of $49.0 million, compared to ($71.0) million in 2024. • Adjusted EBITDA of $115.1 million, up 27% compared to $90.8 million year over year. • Diluted EPS of $0.78, with Adjusted EPS of $1.07 1 . • Cash and cash equivalents totaled $65.6 million at year end, up from $4.7 million at the end of 2024.

View on SEC.gov

Browse all earnings releases →

Guardian Pharmacy Services, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-102153

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.